Companies / Altesa BioSciences
Altesa BioSciences
Atlanta, GA, United States
Altesa BioSciences is developing a medicine to treat rhinovirus infections in chronic lung diseases such as COPD and asthma
Altesa BioSciences, based in Atlanta, GA, United States, has 5 investors on file, among them Atlantic, Forbion and Medicxi. Its latest round on record is Series B, 19 Feb 2026.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Page + round | Venture capital | |
| Portfolio page | Corporate VC |
Recent changes
what VCinfo saw changeA company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Altesa BioSciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atlantic adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/altesa.com/investors
# also
GET /v1/companies/altesa.com
GET /v1/companies/altesa.com/news